{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Source:
INN:iparomlimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tabituximab barzuxetan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04286438: Phase 3 Interventional Completed Hemorrhage
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tabituximab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:rolinsatamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04278924: Phase 2 Interventional Completed Primary Immune Thrombocytopenia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03754309: Phase 2 Interventional Completed Dermatitis, Atopic
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ispectamab debotansine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ispectamab tazide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
